A specific group of fungi residing in the intestines can protect against intestinal injury and influence social behavior, according to new preclinical research by scientists at Weill Cornell Medicine.
Finding innovative solutions for cities’ most pressing problems is a primary goal of the new Urban Tech Hub, part of the Jacobs Technion-Cornell Institute at Cornell Tech.
A gift to establish a new dispute resolution faculty professorship was made through the estate of an inseparable couple who shared their hearts with generations of ILRies.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
A protein called Zbtb46, expressed by specialized immune cells, has a major role in protecting the gastrointestinal tract from excessive inflammation, according to a study from researchers at Weill Cornell Medicine.
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.
An interdisciplinary team led by Cornell has received a five-year grant to launch a new center for engineering, testing and commercializing point-of-care diagnostic devices that will have international reach.
Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.
A summit hosted at Cornell Tech on Feb. 28 brought together more than 50 principals, guidance counselors, students and leaders from community-based organizations to discuss how to grow Cornell’s Bridge Scholars program from a successful pilot initiative into a nation-wide collaborative.